Our study demonstrated a novel paradigm of ESCC progression that involves the orchestration of cancer and non-cancer cells in the tumour micro- and macroenvironments by the Id1/IGF2/VEGF/VEGFR1 cascade (Fig. 9). This evidence concerns the gene IGF2 and neoplasm.